Examkin

Question

Difficulty: MediumOrdering Laboratory Tests

A 26-year-old man presents to the primary care clinic for a routine wellness examination and requests sexually transmitted infection screening. He recently became sexually active with a new male partner and reports inconsistent condom use. He currently feels well and has no symptoms of acute illness. The physician initiates screening for Human Immunodeficiency Virus (HIV). Assuming the patient is in the window of acute early-stage infection (e.g., positive for viral antigens but lacking a mature antibody response), arrange the following laboratory evaluations in the correct chronological sequence according to the standard CDC diagnostic and pre-treatment algorithm.

  1. 1HIV-1/2 antigen/antibody combination immunoassay
  2. 2HIV-1/HIV-2 antibody differentiation immunoassay
  3. 3HIV-1 nucleic acid test (NAT)
  4. 4HIV genotypic drug-resistance testing

Answer

The correct sequence is: 1) HIV-1/2 antigen/antibody combination immunoassay, 2) HIV-1/HIV-2 antibody differentiation immunoassay, 3) HIV-1 nucleic acid test (NAT), and finally 4) HIV genotypic drug-resistance testing.
The correct sequence strictly follows the CDC HIV diagnostic testing algorithm. The initial test must be the highly sensitive fourth-generation antigen/antibody combination assay. If reactive, it is immediately followed by a differentiation immunoassay to distinguish between HIV-1 and HIV-2. In cases of acute early infection, the differentiation assay may return negative or indeterminate because the antibody response has not yet developed. This discordant result necessitates a nucleic acid test (NAT) to confirm the presence of viral RNA. Finally, once the diagnosis is completely confirmed, genotypic resistance testing is ordered before initiating antiretroviral therapy.

Step-by-Step Solution

1
Identify the appropriate initial screening test for HIV.
HIV-1/2 antigen/antibody combination immunoassay.
Current guidelines recommend starting with a fourth-generation assay that detects both the p24 antigen and HIV antibodies to maximize the detection of early acute infections.
2
Determine the next reflex test following a positive initial screen.
HIV-1/HIV-2 antibody differentiation immunoassay.
This test distinguishes between HIV-1 and HIV-2, which is critical for guiding subsequent therapy. In an acute infection, this test is typically indeterminate or negative because the antibody response has not yet fully matured.
3
Determine the confirmatory test for acute infection when discordant initial results occur.
HIV-1 nucleic acid test (NAT).
A reactive initial screen (due to p24 antigen) followed by a negative or indeterminate differentiation assay necessitates NAT to confirm the presence of HIV RNA, thereby solidifying the diagnosis of acute HIV infection.
4
Select the appropriate pre-treatment laboratory evaluation.
HIV genotypic drug-resistance testing.
Once the diagnosis is confirmed, genotypic resistance testing must be ordered prior to initiating antiretroviral therapy to ensure the selected regimen will be fully active against the patient's specific viral strain.

Key Concept

The CDC HIV diagnostic algorithm requires a specific sequence: initial screening with a fourth-generation antigen/antibody assay, reflex testing with an antibody differentiation assay, and confirmation of acute infection with a nucleic acid test (NAT) if the differentiation assay is negative or indeterminate.
Rate this question

Topics

Ordering Laboratory Tests

More questions from this topic